Progression & Monitoring: Protecting Your Liver Health
At a Glance
Hepatitis Delta (HDV) accelerates liver damage faster than Hepatitis B alone, making regular monitoring essential. Patients should undergo an abdominal ultrasound and blood tests every 6 months to screen for cirrhosis and liver cancer, while completely avoiding alcohol to protect their liver.
While Hepatitis Delta (HDV) is a serious condition, your care team has specific tools to monitor your liver health and intervene early. HDV is known for being more aggressive than Hepatitis B alone, but with consistent monitoring, you can stay ahead of the virus and make informed decisions about your treatment [1][2].
The Speed of Progression
The most important reason for frequent check-ups is that HDV can cause liver damage more quickly than other types of viral hepatitis.
- Accelerated Scarring: In people with chronic HBV/HDV, about 50% may develop cirrhosis (advanced liver scarring) within 5 to 10 years [3][4]. This is significantly faster than with Hepatitis B alone [1].
- Increased Risk: HDV patients face a 2 to 3 times higher risk of developing cirrhosis and liver cancer (hepatocellular carcinoma or HCC) compared to those with only Hepatitis B [1][2].
- Decompensation Risk: There is also a higher chance of decompensation, which is when the liver becomes so scarred that it can no longer perform its vital functions [5][4].
Protecting Your Liver Daily
Because HDV accelerates liver damage, it is critical to eliminate other sources of liver stress in your daily life:
- Alcohol: Avoid alcohol entirely, as it significantly increases the speed of liver scarring and the risk of liver cancer [1].
- Medications and Supplements: Always consult your pharmacist or hepatologist before taking over-the-counter medications, particularly those containing acetaminophen, or any herbal supplements. These can cause unintended liver injury [6].
Measuring Your Liver’s Health
Doctors use several methods to track how much scarring (fibrosis) is present in your liver. These tests help determine if your liver is staying stable or if the disease is progressing.
- FibroScan (VCTE): This is a non-invasive, ultrasound-like test that measures liver “stiffness.” The stiffer the liver, the more scarring is likely present [7].
- Blood-Based Scores: Doctors use specific formulas, such as the D4FS score (specifically designed for HDV) or the FIB-4, which combine your age and blood test results (like platelets and liver enzymes) to estimate liver health [8][9].
- Liver Biopsy: While less common now because of better scans, a biopsy involves taking a tiny piece of liver tissue to examine under a microscope. It remains a very accurate way to see the exact stage of the disease [7].
The Surveillance Schedule
Because of the increased risk of liver cancer, regular “surveillance” is essential. Even if you feel perfectly healthy, the goal is to find any changes when they are small and most treatable [2][10].
- Ultrasounds: Most guidelines recommend an abdominal ultrasound every 6 months [11].
- AFP Testing: Your doctor may also check your blood for alpha-fetoprotein (AFP), a protein that can sometimes rise when liver cancer is present [11].
- Consistency is Key: Staying on this 6-month schedule is the single most effective way to protect your long-term health [2][12].
Managing “Scanxiety”
It is completely normal to feel a spike in stress or dread in the days leading up to an ultrasound or when waiting for results. This is often called scanxiety [13].
- The Waiting Period: Most distress occurs right before the scan and during the wait for the phone call or portal notification with your results [13][14].
- Coping Strategies: Learning more about the process, asking your doctor how quickly you’ll get results, and using relaxation techniques can help lower this anxiety [15][16].
- The Big Picture: Remember that these scans are a tool for empowerment. A “clean” scan provides peace of mind, and an early finding provides the best opportunity for successful treatment [2].
By participating in regular monitoring, you are taking an active role in managing the virus and ensuring your liver remains as healthy as possible for as long as possible [10].
Common questions in this guide
How quickly does Hepatitis Delta damage the liver?
What tests are used to monitor liver health in HDV patients?
How often should I get an ultrasound for Hepatitis Delta?
Are there things I should avoid to protect my liver from HDV?
What is scanxiety and how can I manage it?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What was my most recent FibroScan or D4FS score, and what does it tell us about my stage of liver disease?
- 2.Given my HDV status, should we be doing ultrasounds every 6 months even if my liver hasn't reached the cirrhosis stage yet?
- 3.Will you be checking my AFP (alpha-fetoprotein) levels in addition to imaging for my cancer screenings?
- 4.How quickly can I expect to receive results from my scans to help minimize the time I spend waiting and worrying?
- 5.Is my current rate of liver scarring considered 'rapid' or 'stable' based on my last few years of tests?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
New actors come into play against hepatitis delta.
Riveiro-Barciela M, Palom A, Buti M
Revista espanola de enfermedades digestivas 2022; (114(12)):702-704 doi:10.17235/reed.2022.9050/2022.
PMID: 36043543 - 2
Non-Invasive Prediction Scores for Hepatitis B Virus- and Hepatitis D Virus-Infected Patients-A Cohort from the North-Eastern Part of Romania.
Grecu LI, Sultana C, Pavel-Tanasa M, et al.
Microorganisms 2023; (11(12)) doi:10.3390/microorganisms11122895.
PMID: 38138039 - 3
[Chronic HBV and HDV infection].
Rusignuolo G, Thimme R, Neumann-Haefelin C
Deutsche medizinische Wochenschrift (1946) 2024; (149(16)):948-954 doi:10.1055/a-2057-1840.
PMID: 39094599 - 4
Delta hepatitis: Toward improved diagnostics.
Kamili S, Drobeniuc J, Mixson-Hayden T, Kodani M
Hepatology (Baltimore, Md.) 2017; (66(6)):1716-1718 doi:10.1002/hep.29564.
PMID: 28961326 - 5
Hepatitis Delta Virus Testing, Prevalence, and Liver-Related Outcomes Among US Veterans With Chronic Hepatitis B.
Wong RJ, Yang Z, Jou JH, et al.
Gastro hep advances 2025; (4(3)):100575 doi:10.1016/j.gastha.2024.10.015.
PMID: 39906477 - 6
Liver Transplantation for Hepatitis D Virus in the United States: A UNOS Study on Outcomes in the MELD Era.
Kushner T, Da BL, Chan A, et al.
Transplantation direct 2022; (8(1)):e1253 doi:10.1097/TXD.0000000000001253.
PMID: 34957333 - 7
Vibration-controlled transient elastography for the detection of cirrhosis in chronic hepatitis D infection.
Da BL, Surana P, Takyar V, et al.
Journal of viral hepatitis 2020; (27(4)):428-436 doi:10.1111/jvh.13235.
PMID: 31742822 - 8
The Delta-4 fibrosis score (D4FS): A novel fibrosis score in chronic hepatitis D.
Da BL, Surana P, Kleiner DE, et al.
Antiviral research 2020; (174()):104691 doi:10.1016/j.antiviral.2019.104691.
PMID: 31837393 - 9
Letter: changes in FIB-4 cut-off points for viral hepatitis - authors' reply.
Surana P, Takyar V, Koh C
Alimentary pharmacology & therapeutics 2017; (45(7)):1008-1009 doi:10.1111/apt.13974.
PMID: 28256080 - 10
The Changing Face of Hepatitis Delta Virus Associated Hepatocellular Carcinoma.
Cardoso MF, Machado MV
Cancers 2024; (16(22)) doi:10.3390/cancers16223723.
PMID: 39594679 - 11
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.
Journal of hepatology 2018; (69(1)):182-236 doi:10.1016/j.jhep.2018.03.019.
PMID: 29628281 - 12
Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment.
Stella L, Santopaolo F, Gasbarrini A, et al.
World journal of gastroenterology 2022; (28(21)):2251-2281 doi:10.3748/wjg.v28.i21.2251.
PMID: 35800182 - 13
Prevalence and severity of scanxiety in people with advanced cancers: a multicentre survey.
Bui KT, Kiely BE, Dhillon HM, et al.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022; (30(1)):511-519 doi:10.1007/s00520-021-06454-9.
PMID: 34333717 - 14
Prevalence, severity, and modifiable predictors of scanxiety in patients undergoing routine oncologic imaging: a prospective longitudinal study.
Shah MS, Memon JA, Malik U, et al.
Clinical imaging 2025; (128()):110634 doi:10.1016/j.clinimag.2025.110634.
PMID: 41077027 - 15
The experience of patients participating in a small randomised control trial that explored two different interventions to reduce anxiety prior to an MRI scan.
Tugwell-Allsup J, Pritchard AW
Radiography (London, England : 1995) 2018; (24(2)):130-136 doi:10.1016/j.radi.2017.11.001.
PMID: 29605109 - 16
Scanxiety and quality of life around follow-up imaging in patients with unruptured intracranial aneurysms: a prospective cohort study.
Kamphuis MJ, van der Kamp LT, van Eijk RPA, et al.
European radiology 2024; (34(9)):6018-6025 doi:10.1007/s00330-024-10602-0.
PMID: 38311702
This page is for educational purposes only and does not replace professional medical advice. Always consult your hepatologist regarding your specific liver health and monitoring schedule.
Get notified when new evidence is published on Hepatitis delta.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.